South America vs MEA : Global Oligonucleotide Synthesis Market (2024-2032)

Emerging research infrastructure and growing healthcare modernisation continue to influence market evolution across developing regions. In ***, the South America Oligonucleotide Synthesis Market was valued at USD *** million, while the Middle East & Africa reached USD *** million, demonstrating MEA’s comparatively stronger momentum in adopting genomic technologies. Such disparities reflect differences in investment readiness and institutional research capacity within the Oligonucleotide Synthesis Market. In ***, South America is estimated at USD *** million, and MEA is expected to achieve USD *** million, signalling steady but differentiated growth patterns. From *** to ***, both oligonucleotide synthesis markets are anticipated to expand, with South America progressing to USD *** million and MEA rising to USD *** million by ***. This upward trend underscores increasing biotech focus, gradual expansion of diagnostic applications, and progressive enhancement of regional molecular res...